Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

BACKGROUND: Merkel cell carcinoma (MCC) is a highly malignant skin cancer. Despite major treatment improvements during the last decade, up to 50% of patients do not respond to therapy or develop recurrent disease. For these patients, alternative treatment options are urgently needed. Here, we assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Chteinberg, Emil, Wetzels, Suzan, Gerritsen, Wouter, Temmerman, Lieve, van den Oord, Joost, Biessen, Erik, Kurz, Anna Kordelia, Winnepenninckx, Véronique, Zenke, Martin, Speel, Ernst-Jan, zur Hausen, Axel
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7739210/
https://ncbi.nlm.nih.gov/pubmed/33403016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920975621
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados